human | Q5 |
P106 | occupation | researcher | Q1650915 |
Q90684117 | 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques |
Q33227138 | A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease |
Q51219587 | A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". |
Q84882777 | A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial |
Q46000101 | A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. |
Q39639362 | Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression |
Q92529195 | Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study |
Q60302323 | Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study |
Q53600197 | Age-related effects of smoking on coronary artery disease assessed by gray scale and virtual histology intravascular ultrasound. |
Q85227295 | Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology-intravascular ultrasound |
Q51545745 | Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study. |
Q81514556 | Assessing intermediate left main coronary lesions using intravascular ultrasound |
Q93061032 | Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study) |
Q88995368 | Bleeding Severity After Percutaneous Coronary Intervention |
Q44115463 | Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study |
Q39438758 | Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). |
Q52643133 | Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. |
Q39639368 | Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes |
Q39309085 | Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study |
Q53598043 | Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study. |
Q46834205 | Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings |
Q53163072 | Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography. |
Q92572703 | Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study) |
Q73246222 | Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries |
Q53318664 | Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). |
Q86965099 | Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study |
Q34261694 | Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation |
Q60453518 | Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy |
Q38886576 | Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. |
Q51352499 | Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. |
Q39360380 | Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration |
Q43744821 | Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. |
Q53419376 | Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study. |
Q44464832 | Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk |
Q51805744 | Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy. |
Q87447221 | Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study |
Q40319620 | Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials |
Q57132788 | Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) |
Q48356240 | Dual catheter technique for the treatment of severe coronary artery perforations |
Q40112204 | Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials |
Q50188567 | Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative |
Q38981526 | Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. |
Q38418337 | Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents |
Q47297262 | Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials |
Q38400391 | Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial |
Q46977189 | Enhanced stent imaging improves the diagnosis of stent underexpansion and optimizes stent deployment |
Q38398711 | Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study |
Q46038954 | Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. |
Q38402937 | Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES. |
Q51352493 | Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. |
Q92315017 | Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry |
Q30450312 | High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study |
Q40774686 | Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study |
Q45064792 | Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study |
Q40736980 | Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Dr |
Q91748345 | Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents |
Q46262291 | Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). |
Q90348560 | Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study) |
Q91040575 | Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study |
Q53476914 | Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy. |
Q57169159 | Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents |
Q91266467 | Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy |
Q85090019 | Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) t |
Q43918642 | Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents |
Q56985462 | Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction t |
Q56334747 | Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation |
Q46887976 | Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT. |
Q51375652 | Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. |
Q34637924 | Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial |
Q61634113 | In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy |
Q86833661 | In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound |
Q38885545 | Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry |
Q41445718 | Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention |
Q88461145 | Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis |
Q48942460 | Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy. |
Q28199551 | Intracoronary radiation to treat in-stent restenosis in six cardiac transplant patients |
Q40410810 | Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts |
Q83297062 | Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts |
Q84768530 | Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation |
Q57213766 | Intravascular ultrasound comparison of left main coronary artery disease between white and Asian patients |
Q40996236 | Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). |
Q38704416 | Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration |
Q84974281 | Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocard |
Q44079627 | Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes |
Q86122458 | Lumen Measurements From Quantitative Coronary Angiography and IVUS: A PROSPECT Substudy |
Q44880417 | Magnetic positioning system in coronary angiography and percutaneous intervention: a feasibility and safety study |
Q53594171 | Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study. |
Q40531601 | Multi-laboratory inter-institute reproducibility study of IVOCT and IVUS assessments using published consensus document definitions |
Q51224812 | Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study. |
Q57741468 | On-pump versus off-pump surgical revascularization in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial |
Q38432604 | Optical coherence tomographic evaluation of transplant coronary artery vasculopathy with correlation to cellular rejection |
Q51150191 | Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. |
Q53215061 | Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. |
Q90908067 | Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes |
Q38938312 | Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry |
Q38376910 | Percutaneous Coronary Intervention of Saphenous Vein Graft |
Q47711302 | Percutaneous coronary intervention of bifurcation lesions and platelet reactivity |
Q49972170 | Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study |
Q92051559 | Plaque burden can be assessed using intravascular optical coherence tomography and a dedicated automated processing algorithm: a comparison study with intravascular ultrasound |
Q39639379 | Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes |
Q38379501 | Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). |
Q89125284 | Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study |
Q41968141 | Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study |
Q38000673 | Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures |
Q57818728 | Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population |
Q30366121 | Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy. |
Q51222402 | Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy. |
Q87195101 | Prevalence and anatomical features of acute longitudinal stent deformation: An intravascular ultrasound study |
Q38410176 | Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry |
Q38390273 | Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy |
Q51329000 | Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from Providing Regional Observations to Study Predictors of Events in the Coronary Tree ( |
Q83221765 | Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial |
Q38402115 | Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study |
Q40103494 | Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). |
Q51019687 | Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial. |
Q35810820 | Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial |
Q40806431 | Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study |
Q47954675 | Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy). |
Q88084180 | Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study) |
Q90666866 | Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents |
Q91644973 | Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris |
Q51507336 | Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy. |
Q93168012 | Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization |
Q38440568 | Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study |
Q57171844 | Relationship between left main coronary artery plaque burden and nonleft main coronary atherosclerosis: results from the PROSPECT study |
Q47781907 | Relationship of Hospital Teaching Status with In-Hospital Outcomes for ST-Segment Elevation Myocardial Infarction |
Q39639374 | Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention |
Q51462278 | Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study". |
Q33428812 | Revascularization Strategies for Calcified Lesions in Patients Presenting With Acute Coronary Syndromes (From the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial). |
Q51070182 | Robotic-Enhanced PCI Compared to the Traditional Manual Approach. |
Q45969326 | Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention. |
Q60453545 | Safety and Efficacy of High- Versus Low-Dose Aspirin After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction |
Q40812182 | Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis |
Q40126785 | Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis |
Q46529943 | Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials |
Q82727493 | Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease |
Q46090924 | Safety and performance of targeted renal therapy: the Be-RITe! Registry |
Q28222362 | Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy) |
Q85806565 | Serial gray scale intravascular ultrasound findings in late drug-eluting stent restenosis |
Q38380899 | Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). |
Q50229683 | Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study |
Q46834201 | Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. |
Q40785204 | Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry |
Q46420633 | Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study |
Q42851156 | Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial |
Q46981339 | The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions |
Q50675914 | The association between experience and proficiency with robotic-enhanced coronary intervention-insights from the PRECISE multi-center study. |
Q43202648 | The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. |
Q38886583 | Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry |
Q46911870 | Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. |
Q64355427 | Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States⋆ |
Q50979607 | Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. |
Q51236297 | Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. |
Q83078618 | Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry) |
Q45195984 | Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial |
Q38976342 | Usefulness of Beta2-Microglobulin as a Predictor of All-Cause and Nonculprit Lesion-Related Cardiovascular Events in Acute Coronary Syndromes (from the PROSPECT Study). |
Q51752078 | Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). |
Q47976208 | Validation Study of Image-Based Fractional Flow Reserve During Coronary Angiography |
Q86641222 | Virtual histology intravascular ultrasound comparison of coronary chronic total occlusions versus non-occlusive lesions |
Q51098019 | Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. |
Q50061984 | White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry). |
Search more.